|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Accounts receivable - Book Value | |||||||||
| Due from related parties, short term | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Inventories | |||||||||
| Assets held for sale - Book Value | |||||||||
| Total current assets | |||||||||
| Vessels, net | |||||||||
| Deferred finance costs, net | |||||||||
| Intangible assets other than goodwill | |||||||||
| Goodwill | |||||||||
| Other long-term assets | |||||||||
| Deferred dry dock and special survey costs, net | |||||||||
| Investment in affiliates | |||||||||
| Due from related parties, long-term - Book Value | |||||||||
| Operating lease assets | |||||||||
| Total non-current assets | |||||||||
| Total assets | |||||||||
| Accounts payable | |||||||||
| Accrued expenses | |||||||||
| Due to related parties, short-term | |||||||||
| Dividends payable | |||||||||
| Deferred revenue | |||||||||
| Long-term debt including current portion, net of deferred finance costs and discount | |||||||||
| Liabilities associated with assets held for sale | |||||||||
| Operating lease liability, current | |||||||||
| Total current liabilities | |||||||||
| Long-term debt, net of current portion, premium and net of deferred finance costs | |||||||||
| Deferred gain on sale of assets | |||||||||
| Operating lease liability, non-current | |||||||||
| Total non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Commitments and contingencies | |||||||||
| No shares of Preferred stock is issued and outstanding, $0.0001 par value; 10,000,000 shares authorized; no shares of Series C issued and outstanding as of December 31, 2020 and as of December 31, 2019 | |||||||||
| Common stock, $0.0001 par value; 250,000,000 shares authorized; 16,559,481 and 15,873,391 issued and outstanding as of December 31, 2020 and December 31, 2019, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders’ equity | |||||||||
| Total liabilities and stockholders’ equity | |||||||||
Loading...
